4//SEC Filing
Eansor Norman David 4
Accession 0001209191-22-032166
CIK 0001094038other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:08 PM ET
Size
5.7 KB
Accession
0001209191-22-032166
Insider Transaction Report
Form 4
EANSOR N DAVID
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-24+80,000→ 80,000 totalExercise: $0.34Exp: 2032-05-23→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This option vests on May 24, 2023, subject to the Reporting Person's continued service as a director through the vesting date.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001270905
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:08 PM ET
- Size
- 5.7 KB